Judge Boosts Juno and Sloan Kettering’s Patent Award to $1.2B
In April 2020, Irell convinced a judge to enhance a jury’s damages by 50 percent, increasing an award the firm secured for Juno Therapeutics, Inc. and Sloan Kettering Institute for Cancer Research to $1.2 billion. The jury’s $752 million verdict, reached in December 2019, was the largest patent jury award in the U.S. last year. The enhancement is based on a patent law provision that allows a court to increase damages to punish infringers for egregious conduct. The jury found that Kite willfully infringed the patent for cancer immunotherapy.
Judge S. James Otero of the U.S. District Court for the Central District of California also denied Kite’s motion for judgment as a matter of law and motion for a new trial.
The Irell team includes Morgan Chu, Alan Heinrich, Maclain Wells, Elizabeth Tuan, Michael Fleming, Rebecca Carson and Ingrid Petersen. Jones Day is co-counsel with Irell.